Integrated management of depression: Improving system quality and creating effective interfaces

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 4, 2008, Pages 482-491

  Myette, Thomas L ^a,b,c  

^a Health Employers Association of British Columbia   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Healthcare Benefit Trust ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

COMORBIDITY; DEPRESSION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; OCCUPATIONAL HEALTH; PREVALENCE; PREVENTION AND CONTROL; PSYCHOTHERAPY; PUBLIC HEALTH SERVICE; REVIEW; SELF CARE; TOTAL QUALITY MANAGEMENT; WORK DISABILITY; WORKPLACE;

EID: 42049104119     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31816a9ea6     Document Type: Article

References (53)

1. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
2. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res. 2003;12:22-33.
3. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorder on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163:1561-1568.
4. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry. 2005;62:1097-1106.
5. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorders: results from the national comorbidity survey replication. JAMA. 2003;289:3095-3105.
6. Patten SB, Wang JL, Williams JVA, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84-90.
7. Gilmour H, Patten SB. Depression and work impairment. Health Rep. 2007;18:9-22.
8. Burton WN, Pransky G, Conti DJ, Chen C, Edington DW. The association of medical conditions and presenteeism. J Occup Environ Med. 2004;46:S38-S45.
9. Goetzel RW, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting us employers. J Occup Environ Med. 2004;46:398-412.
10. Collins JJ, Baase CM, Sharda CE, et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med. 2005;47:547-557.
11. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff. 1999;18:163-171.
12. Dewa CS, Goering P, Lin E, Paterson M. Depression-related short-term disability in an employed population. J Occup Environ Med. 2002;44:628-633.
13. Patten SB. Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry. 1999;44:151-157.
14. Chapman DP, Perry GS, Strine TW. The vital link between chronic disease and depressive disorders. Prev Chronic Dis. 2005;2. Available at: http://www.cdc.gov/pcd/issues/2005/jan/04_0066.htm.
15. Ungar TE, Katon WJ, Wulsin LR, et al. Double jeopardy. Depression & medical illness: interactions and outcomes. Patient Care. 2006:35-44.
16. Wang PS, Beck A, Berglund P, et al. Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys. J Occup Environ Med. 2003;45:1303-1311.
17. Peele PB, Tollerud DJ. Depression and occupational injury: results of a pilot investigation. J Occup Environ Med. 2005;47:424-427.
18. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in manager primary care. JAMA. 2000;283:212-220.
19. Depression Guideline Panel. Clinical Practice Guideline, Depression in primary Care: Volume 2. Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research; 1993. AHCPR publication no. 93-0551.
20. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157(suppl 4):1-45.
21. Canadian Psychiatric Association. Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry. 2001;46(suppl 1):38S-58S.
22. Andrews G. Should depression be managed as a chronic disease? BMJ. 2001;322:419-421.
23. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511-543.
24. Unutzer J, Schoenbaum M, Druss BG, Katon WJ. Transforming mental health care at the interface with general medicine: report for the President's commission. Psychiatr Serv. 2006;57:37-47.
25. Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20:64-78.
26. World Health Organization. Innovative Care for Chronic Conditions. Building Blocks for Action. WHO; 2002.
27. Norris SL, Nichols PJ, Caspersen CJ, et al. The effectiveness of disease and case management for people with diabetes. Am J Prev Med. 2002;22(suppl 4):15-38.
28. Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programs for patients with chronic illness - which ones work? Meta-analysis of published reports. BMJ. 2002;325:925.
29. Badamgarav E, Weingarten SR, Hennings JM, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003;160:2080-2090.
30. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression. a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004;42:2111-1221.
31. Ofman JJ, Badamgarav K, Henning JM, et al. Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med. 2004;117:182-192.
32. Kates N, Mach M. Chronic disease management for depression in primary care: a summary of the current literature and implications for practice. Can J Psychiatry. 2007;52:77-85.
33. Department of Health UK. The Expert Patient: A New Approach to Chronic Disease Management for the 21st Century. Department of Health; 2001. Available at: http://www.doh.gov.uk/healthinequalities.
34. Lorig K, Holman H, Sobel D, et al. Living a Healthy Life with Chronic Conditions. Palo Alto, CA: Bull Publishing Company; 1993.
35. Chodosh J, Morton SC, Mojica W, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143:427-438.
36. Ludman EJ, Simon GE, Grothaus LC, Luce C, Markley DK, Schaefer J. A pilot study of telephone care management and structured disease self-management groups for chronic depression. Psychiatr Serv. 2007;58:1065-1072.
37. Cuijpers P. Bibliotherapy in unipolar depression: a meta-analysis. J Behav Ther Exp Psychiatry. 1997;28:139-147.
38. Marrs RW. A meta-analysis of bibliotherapy studies. Am J Community Psychol. 1995;23:843-870.
39. McKendree-Smith NL, Floyd M, Scogin FR. Self-administered treatments for depression: a review. J Clin Psychol. 2003;59:275-288.
40. Den Boer PCAM, Wiersma D, Van Den Bosch RJ. Why is self-help neglected in the treatment of emotional disorders? A meta-analysis. Psychol Med. 2004;34:959-971.
41. Bilsker D, Gilbert M, Samra J Antidepressant Skills At Work: Dealing with Mood Problems in the Workplace. 2007. Available at: http://www.carmha.ca/ publications.
42. Adler DA, McLaughlin TJ, Rogers WH, et al. Job performance deficits due to depression. Am J Psychiatry. 2006;163:1569-1576.
43. Rost K, Smith JL, Dickson M. The effect of improving primary care depression management on employee absenteeism and productivity. Med Care. 2004;42:1202-1210.
44. Wang PS, Patrick A, Avorn J, et al. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry. 2006;63:1345-1353.
45. Lo Sasso AT, Rost K, Beck A. Modeling the impact of enhanced depression treatment on workplace functioning and costs. A cost-benefit approach. Med Care. 2006;44:352-358.
46. Aldana S. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot. 2001;15:296-320.
47. Chapman LS. Meta-evaluation of worksite health promotion economic return studies. Art Health Promo. 2003;6:1-15.
48. Pelletier KR. A review and analysis of clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: update IV 2000-2004. J Occup Environ Med. 2005;47:1051-1058.
49. Kessler RC, Stang PE. Future directions in health and work productivity research. In: Kessler RC, Stang PE, eds. Health & Work Productivity: Making the Business Case for Quality Health Care. Chicago: The University of Chicago Press; 2006:271-286.
50. Goetzel RZ, Shechter D, Ozminkowski RJ, et al. Promising practices in employer health and productivity management efforts: findings from a benchmarking study. J Occup Environ Med. 2007;49:111-130.
51. Bilsker D, Gilbert M, Myette TL, Stewart-Patterson C. Depression & Work Function: Bridging the Gap Between Mental Health Care & the Workplace. 2004. Available at: http://www.carmha.ca/publications.
52. Gensichen J, Beyer M, Muth C, et al. Case management to improve major depression in primary health care: a systematic review. Psychol Med. 2005;35:1-8.
53. Leatherman S, Berwick D, Iles D et al. The business case for quality: case studies and an analysis. Health Aff. 2003;22:17-30.